Literature DB >> 20658372

Benzodiazepine use and quality of sleep in the community-dwelling elderly population.

Sarah-Gabrielle Beland1, Michel Preville, Marie-France Dubois, Dominique Lorrain, Sebastien Grenier, Philippe Voyer, Guilheme Perodeau, Yola Moride.   

Abstract

BACKGROUND: About 50% of the elderly population report being dissatisfied with their sleep. Although benzodiazepines are the most prescribed drugs to treat sleep complaints, the effectiveness of their use on the quality of sleep is not well documented.
OBJECTIVES: This study aimed to assess the association between benzodiazepine use and global sleep quality, as well as six components of sleep quality.
METHODS: Data from the cross-sectional Quebec Survey on Seniors' Health (n = 2798) conducted in 2005-2006 were used. Quality of sleep was self-reported and use of benzodiazepines was assessed during the previous year.
RESULTS: Benzodiazepine users reported poorer quality of sleep than non-users. The association between benzodiazepine use and each of the six quality of sleep components studied were similar except for the daytime dysfunction component.
CONCLUSION: The results suggest that there is no evidence that using benzodiazepines is associated with better quality of sleep than non-users in the elderly population. Future longitudinal population-based studies are needed to assess improvements in quality of sleep in the elderly associated with the use of benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20658372     DOI: 10.1080/13607861003781833

Source DB:  PubMed          Journal:  Aging Ment Health        ISSN: 1360-7863            Impact factor:   3.658


  15 in total

1.  Prevalence and correlates of psychotropic medication use among older adults in Israel: cross-sectional and longitudinal findings from two cohorts a decade apart.

Authors:  Tzvia Blumstein; Yael Benyamini; Angela Chetrit; Eliyahu H Mizrahi; Liat Lerner-Geva
Journal:  Aging Ment Health       Date:  2012       Impact factor: 3.658

Review 2.  Benzodiazepine Use, Misuse, and Harm at the Population Level in Canada: A Comprehensive Narrative Review of Data and Developments Since 1995.

Authors:  Yoko Murphy; Emily Wilson; Elliot M Goldner; Benedikt Fischer
Journal:  Clin Drug Investig       Date:  2016-07       Impact factor: 2.859

3.  One-year evolution of sleep quality in older users of benzodiazepines: a longitudinal cohort study in belgian nursing home residents.

Authors:  Jolyce Bourgeois; Monique M Elseviers; Luc Van Bortel; Mirko Petrovic; Robert H Vander Stichele
Journal:  Drugs Aging       Date:  2014-09       Impact factor: 3.923

4.  Experiences of sleep and benzodiazepine use among older women.

Authors:  Sarah L Canham; Robert L Rubinstein
Journal:  J Women Aging       Date:  2015-01-12

5.  Psychiatrist decision-making towards prescribing benzodiazepines: the dilemma with substance abusers.

Authors:  Carla Beth Marienfeld; Ece Tek; Esperanza Diaz; Richard Schottenfeld; Marek Chawarski
Journal:  Psychiatr Q       Date:  2012-12

Review 6.  [Sleep disorders in dementia patients].

Authors:  E Savaskan
Journal:  Z Gerontol Geriatr       Date:  2015-05-09       Impact factor: 1.281

7.  Effects of pregabalin in patients with hypnotic-dependent insomnia.

Authors:  Youg Won Cho; Mei Ling Song
Journal:  J Clin Sleep Med       Date:  2014-05-15       Impact factor: 4.062

8.  Benzodiazepine (BZD) use in community-dwelling older adults: Longitudinal associations with mobility, functioning, and pain.

Authors:  Megan E Petrov; Patricia Sawyer; Richard Kennedy; Laurence A Bradley; Richard M Allman
Journal:  Arch Gerontol Geriatr       Date:  2014-05-06       Impact factor: 3.250

Review 9.  Prescription Benzodiazepine Use Among Older Adults: A Critical Review.

Authors:  Lauren B Gerlach; Ilse R Wiechers; Donovan T Maust
Journal:  Harv Rev Psychiatry       Date:  2018 Sep/Oct       Impact factor: 3.732

10.  Sleep cognitions associated with anxiety and depression in the elderly.

Authors:  Marie-France Leblanc; Sophie Desjardins; Alain Desgagné
Journal:  Clin Interv Aging       Date:  2015-03-16       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.